Benefit of extending anticoagulation therapy lost after discontinuation of therapy
2015-07-07
(Press-News.org) Among patients with a first episode of pulmonary embolism (the obstruction of the pulmonary artery or a branch of it leading to the lungs by a blood clot) who received 6 months of anticoagulant treatment, an additional 18 months of treatment with warfarin reduced the risk of additional blood clots and major bleeding, however, the benefit was not maintained after discontinuation of anticoagulation therapy, according to a study in the July 7 issue of JAMA.
When anticoagulant therapy is stopped after 3 to 6 months of treatment, patients with a first episode of unprovoked (no major risk factor) venous thromboembolism (blood clot within a vein) have a much higher risk of recurrence than those with venous thromboembolism provoked by a transient risk factor (e.g., surgery). In this high-risk population, extending anticoagulation beyond 3 to 6 months is associated with a reduction in the risk of recurrence as long as treatment is continued. However, whether this benefit is maintained thereafter has been uncertain because most previous studies did not include follow-up of patients after discontinuation of treatment, according to background information in the article.
Francis Couturaud, M.D., Ph.D., of the Universite de Bretagne Occidentale, Brest, France, and colleagues conducted a study that included 371 adult patients who had experienced a first episode of symptomatic unprovoked pulmonary embolism (i.e., with no major risk factor for a blood clot) and had been treated initially for 6 uninterrupted months with a vitamin K antagonist. The patients were randomly assigned to warfarin or placebo for 18 months; median follow-up was 24 months. The trial was conducted at 14 French centers.
After randomization, 4 patients were lost to follow-up, all after month 18, and 1 withdrew due to an adverse event. During the 18-month treatment period, the primary outcome (the composite of recurrent venous thromboembolism or major bleeding at 18 months after randomization) occurred in 6 of 184 patients (3 percent) in the warfarin group and in 25 of 187 patients (13.5 percent) in the placebo group, resulting in a relative risk reduction of 78 percent in favor of warfarin. This result was driven by a reduction in the risk of recurrent venous thromboembolism, with the risk of bleeding increasing to a minimal extent.
This benefit of anticoagulation was lost after anticoagulation was discontinued. During the 42-month entire study period (including the study treatment and follow-up periods), the composite outcome occurred in 33 patients (21 percent) in the warfarin group and in 42 (24 percent) in the placebo group. Rates of recurrent venous thromboembolism, major bleeding, and unrelated death did not differ between groups.
The authors note that their results suggest that patients such as those who participated in this study require long-term secondary prevention measures. "Whether these should include systematic treatment with vitamin K antagonists, new anticoagulants or aspirin, or be tailored according to patient risk factors needs further investigation."
INFORMATION:
(doi:10.1001/jama.2015.7046; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: The study was supported by grants from the Programme Hospitalier de Recherche Clinique (French Department of Health), and the sponsor was the University Hospital of Brest. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.
Please Note: There is related content in this issue of JAMA on this topic. These articles, along with a podcast, are available to the media at http://media.jamanetwork.com.
Long-term vs Short-term Therapy With Vitamin K Antagonists for Symptomatic Venous Thromboembolism
Computed Tomographic Pulmonary Angiography for Pulmonary Embolism
Edoxaban (Savaysa) - The Fourth New Oral Anticoagulant
Treatment Duration for Pulmonary Embolism
ELSE PRESS RELEASES FROM THIS DATE:
2015-07-07
After years of overtreatment for patients with low-risk prostate cancer, rates of active surveillance/ watchful waiting increased sharply in 2010 through 2013, and high-risk disease was more often treated appropriately with potentially curative local treatment rather than androgen deprivation alone, according to a study in the July 7 issue of JAMA.
Matthew R. Cooperberg, M.D., M.P.H., and Peter R. Carroll, M.D., M.P.H., of the University of California, San Francisco, conducted a study to examine recent trends in community-based practice patterns of the management of localized ...
2015-07-07
For women with Lynch syndrome, an association was found between the risk of endometrial cancer and the age of first menstrual cycle, having given birth, and hormonal contraceptive use, according to a study in the July 7 issue of JAMA. Lynch syndrome is a genetic condition that increases the risk for various cancers.
Endometrial cancer is the most common type of gynecologic cancer in developed countries. Between 2 percent and 5 percent of all endometrial cancer cases are associated with a hereditary susceptibility to cancer, mainly Lynch syndrome, which is caused by a ...
2015-07-07
Life expectancy for people with a history of both cardiovascular disease and diabetes is substantially lower than for people with just one condition or no disease, a new study harnessing the power of 'big data' has concluded.
Researchers at the University of Cambridge analysed more than 135,000 deaths which occurred during prolonged follow-up of almost 1.2 million participants in population cohorts. They used this to provide estimates of reductions in life expectancy associated with a history of different combinations of diabetes, stroke, and/or myocardial infarction ...
2015-07-07
Rejection of transplanted organs in hosts that were previously tolerant may not be permanent, report scientists from the University of Chicago. Using a mouse model of cardiac transplantation, they found that immune tolerance can spontaneously recover after an infection-triggered rejection event, and that hosts can accept subsequent transplants as soon as a week after. This process depends on regulatory T-cells, a component of the immune system that acts as a "brake" for other immune cells. The findings, published online in Nature Communications on July 7, support inducing ...
2015-07-07
ANN ARBOR, Mich. -- A stroke happens in an instant. And many who survive one report that their brain never works like it once did. But new research shows that these problems with memory and thinking ability keep getting worse for years afterward - and happen faster than normal brain aging.
Stroke survivors also had a faster rate of developing cognitive impairment over the years after stroke compared to their pre-stroke rate. The study results are published in the Journal of the American Medical Association this week.
"We found that stroke is associated with cognitive ...
2015-07-07
The Vancouver 2010 Olympic Games brought more than just athletes to B.C. It also left the province with a bad case of the measles.
In research outlined today in the Journal of Infectious Diseases, scientists at the University of British Columbia and the B.C. Centre for Disease Control used genetic sequencing to trace the 2010 measles outbreak, linking it back to an influx of visitors during the Winter Olympics.
"In 2010, we had two visitors, probably from separate parts of the world, who each brought one genotype of measles with them," said lead author Jennifer Gardy, ...
2015-07-07
HOUSTON - (July 7, 2015) - Companies that want to increase customers' loyalty and get their repeat business would do well to understand the nuanced ways in which and reasons why a customer is committed to that company, according to a recent study by marketing experts at Rice University and Fordham University. The research provides a strategic blueprint for developing customer commitment.
The researchers tested a customer-commitment model that has five dimensions -- affective, normative, economic, forced and habitual. They said previous research has used an "insufficient" ...
2015-07-07
LAWRENCE -- A wide-ranging study of gains and losses of populations of bird species across Mexico in the 20th century shows shifts in temperature due to global climate change are the primary environmental influence on the distributions of bird species.
"Of all drivers examined ... only temperature change had significant impacts on avifaunal turnover; neither precipitation change nor human impacts on landscapes had significant effects," wrote the authors of the study, which appeared recently in the peer-reviewed journal Science Advances.
Using analytical techniques from ...
2015-07-07
URBANA, Ill. - A recent study looked at marijuana and alcohol use in people between the ages of 18 and 24. It's probably not surprising that the results show a drastic increase in alcohol consumption in people just over 21; after all, that's the minimum legal age to drink. What University of Illinois economist Ben Crost found remarkable is that, at the same age, there was an equally dramatic drop in marijuana use.
"Alcohol appears to be a substitute for marijuana. This sudden decrease in the use of marijuana is because they suddenly have easy access to alcohol," Crost ...
2015-07-07
ATLANTA--Structural brain abnormalities in patients with schizophrenia, providing insight into how the condition may develop and respond to treatment, have been identified in an internationally collaborative study led by a Georgia State University scientist.
Scientists at more than a dozen locations across the United States and Europe analyzed brain MRI scans from 2,028 schizophrenia patients and 2,540 healthy controls, assessed with standardized methods at 15 centers worldwide. The findings, published in Molecular Psychiatry, help further the understanding of the mental ...
LAST 30 PRESS RELEASES:
[Press-News.org] Benefit of extending anticoagulation therapy lost after discontinuation of therapy
